V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002394 | 230006840 | 1.56 | 69.6 | null | 2018-09-17 | 2018-09-19 | GEMCITABINE | 02 | null | CISPLATIN + ETOPOSIDE | 100074082 |
| 230002397 | 230006842 | 1.76 | 72.8 | null | null | 2019-09-05 | Niraparib | 02 | null | NIRAPARIB | 100077095 |
| 230002398 | 230006843 | null | null | Palliative (P) | null | 2018-07-29 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101454778 |
| 230002401 | 230006844 | 1.55 | 100.4 | Palliative (P) | null | 2020-05-21 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100698941 |
| 230002402 | 230006845 | 1.61 | 55.4 | Adjuvant (A) | null | 2020-02-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100543219 |
| 230002403 | 230006846 | null | null | null | 2019-06-06 | 2019-06-16 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 100891731 |
| 230002405 | 230006847 | 1.61 | 99.8 | Palliative (P) | 2020-07-11 | 2020-07-26 | LIPOSOMAL DOXORUBICIN | 02 | N | LIPOSOMAL DOXORUBICIN | 100323388 |
| 230002409 | 230006849 | null | null | Palliative (P) | 2016-02-09 | 2016-03-07 | Bevacizumab 7.5mg/kg | 02 | N | BEVACIZUMAB | 100843848 |
| 230002410 | 230006850 | 1.54 | 58.2 | null | 2015-05-23 | 2019-11-12 | null | 02 | null | PEMBROLIZUMAB | 100477175 |
| 230002411 | 230006851 | 1.67 | 68 | null | 2019-03-02 | 2020-10-07 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101215995 |
| 230002412 | 230006852 | 1.79 | 67 | null | 2016-08-09 | 2016-08-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101528187 |
| 230002416 | 230006853 | null | null | null | 2019-10-03 | 2019-10-05 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 100430655 |
| 230002417 | 230006854 | null | null | Palliative (P) | 2016-03-07 | 2018-01-20 | null | null | N | ICON8B TRIAL | 101527762 |
| 230002418 | 230006855 | null | null | null | 2020-03-09 | 2020-03-11 | null | null | null | PACLITAXEL | 101513177 |
| 230002421 | 230006858 | 1.65 | 94.6 | null | 2019-11-02 | 2020-01-27 | null | null | null | CISPLATIN + LIPOSOMAL DOXORUBICIN | 100811077 |
| 230002422 | 230006859 | 1.6 | null | Neo-adjuvant (N) | null | 2019-10-18 | Bevacizumab | 02 | null | BEVACIZUMAB | 101577502 |
| 230002423 | 230006860 | null | null | Palliative (P) | 2019-12-07 | 2019-12-12 | null | null | N | CISPLATIN | 101652568 |
| 230002424 | 230006861 | null | null | Adjuvant (A) | 2020-03-12 | 2020-03-19 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100346889 |
| 230002426 | 230006862 | null | null | Palliative (P) | null | 2019-07-17 | null | null | N | ICON8B TRIAL | 100842547 |
| 230002427 | 230006863 | 1.59 | 71.5 | null | 2019-11-29 | 2019-11-29 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100108323 |
| 230002430 | 230006864 | 1.66 | 69.3 | Palliative (P) | 2021-10-13 | 2021-11-04 | Niraparib | 02 | N | NIRAPARIB | 101688027 |
| 230002431 | 230006865 | 1.62 | 81 | Palliative (P) | 2018-02-24 | 2019-12-24 | null | N | N | TREOSULFAN | 100286315 |
| 230002432 | 230006866 | 1.59 | 69.9 | null | 2021-11-27 | 2021-11-30 | null | 02 | N | ETOPOSIDE | 100148290 |
| 230002434 | 230006867 | 1.58 | 64 | null | 2021-03-09 | 2021-03-22 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100179872 |
| 230002435 | 230006868 | 1.58 | 56 | Neo-adjuvant (N) | null | 2020-06-01 | null | 02 | N | TRIAL UNSPECIFIED | 100105739 |
| 230002438 | 230006870 | null | null | null | 2019-06-04 | 2021-09-29 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100242657 |
| 230002441 | 230006872 | null | null | null | null | 2019-11-21 | Niraparib | 02 | null | NIRAPARIB | 101575493 |
| 230002445 | 230006874 | 1.76 | 59 | null | 2019-05-27 | 2019-11-24 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100017993 |
| 230002446 | 230006875 | 1.71 | 80 | Adjuvant (A) | 2018-12-13 | 2019-03-16 | null | 01 | Y | PACLITAXEL | 100751409 |
| 230002447 | 230006876 | null | null | Palliative (P) | null | 2021-04-10 | null | N | N | CARBOPLATIN | 101209559 |
| 230002452 | 230006878 | 1.5 | 110 | null | 2019-09-29 | 2019-09-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100658641 |
| 230002453 | 230006879 | null | null | null | 2020-01-04 | 2020-01-16 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100198779 |
| 230002454 | 230006880 | 1.62 | 70.4 | null | 2021-06-29 | 2021-07-04 | PACLITAXEL | 02 | null | PACLITAXEL | 100423644 |
| 230002456 | 230006882 | 1.6 | 67 | null | 2018-11-16 | 2018-11-19 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101871570 |
| 230002457 | 230006883 | null | null | null | null | 2020-07-19 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100471205 |
| 230002458 | 230006884 | 1.72 | 101 | null | null | 2020-05-30 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN | 101061713 |
| 230002459 | 230006885 | 1.5 | 65.2 | null | null | 2017-07-15 | null | null | null | CYCLOPHOSPHAMIDE | 101538659 |
| 230002460 | 230006886 | 1.63 | 52 | Adjuvant (A) | null | 2019-04-26 | null | null | N | CARBOPLATIN + GEMCITABINE | 100702198 |
| 230002462 | 230006888 | null | null | null | 2019-10-21 | 2019-10-28 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100217599 |
| 230002463 | 230006889 | 1.66 | 81.95 | null | 2021-09-10 | 2021-10-02 | null | 02 | null | DOXORUBICIN | 101083263 |
| 230002466 | 230006892 | 1.57 | 72.4 | null | 2016-07-02 | 2017-12-30 | null | 02 | null | TRIAL UNSPECIFIED | 101067349 |
| 230002467 | 230006893 | 1.64 | 72.3 | null | 2021-07-15 | 2021-07-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101109514 |
| 230002468 | 230006894 | 1.62 | 52.3 | null | 2019-06-12 | 2019-07-29 | PACLITAXEL | 02 | null | PACLITAXEL | 101328624 |
| 230002469 | 230006895 | 1.58 | 71.55 | null | null | 2016-06-22 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100253053 |
| 230002470 | 230006896 | 1.53 | 61.8 | Adjuvant (A) | null | 2019-06-25 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100266774 |
| 230002472 | 230006898 | 1.78 | 56.15 | null | 2020-01-30 | 2020-01-30 | EC | 02 | null | TRIAL UNSPECIFIED | 100269328 |
| 230002475 | 230006899 | 1.65 | 57 | Palliative (P) | null | 2020-05-30 | null | 02 | N | PEMBROLIZUMAB | 101761464 |
| 230002476 | 230006900 | 1.61 | 54.9 | null | 2017-04-02 | 2017-09-01 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101211855 |
| 230002477 | 230006901 | null | 70.5 | Neo-adjuvant (N) | 2019-11-08 | 2019-11-09 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100649742 |
| 230002482 | 230006904 | null | null | null | 2018-10-07 | 2018-10-24 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100170870 |